Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
Press releases
- Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
- FDA approves Trelegy Ellipta as the first once-daily single inhaler triple therapy for the treatment of both asthma and COPD in the US
- Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate
GSK US Twitter
-
GSKUS @GSKUS
Missed our announcement yesterday about our $10M commitment over 10 yrs. to help increase the number of diverse students in #Philly who become #STEM professionals? Hear more from Maya, our President, US Pharma on how we’re confronting inequity in STEM 👉gsk.to/2DT352x8o
about 43 days ago -
GSKUS @GSKUS
#MultipleMyeloma is the second most common form of blood #cancer, with an estimated 32,000 new cases of the disease to be diagnosed in the U.S. in 2020.
about 43 days ago
-
GSK in the US
GSK is dedicated to helping grow the US economy and supporting communities by creating high-quality jobs in areas like R&D, manufacturing, and sales.
-
Pharmaceuticals
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
-
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
-
Consumer Healthcare
Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
